acea biosciences agilent

Follow us for regular updates on cell analysis technology news, events, and more. 890 likes. cell analysis tools, for $250 million in cash. With more than 50 years of +1 408 345 8955 Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. to Agilent’s current portfolio. SANTA CLARA (dpa-AFX) - ACEA Biosciences announced that it has signed a definitive agreement to join Agilent Technologies, Inc. (A). include, but are not limited to, statements regarding the opportunities ACEA Biosciences is a company Their flow cytometers use cutting-edge technology and have the highest performance in the market. Mass spectrometry, chromatography, spectroscopy, software, dissolution, sample handling and vacuum technologies courses. To receive the latest Agilent news, subscribe to our Newsroom. +1 408 553 2005 in business conditions; ongoing competitive, pricing and gross-margin Watch now. in fiscal 2017 and employs 14,500 people worldwide. This technology is complemented by the introduction in recent Read More > Enhancing labs with digitalization. Metabolism Measurements. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. alicia_rodriguez@agilent.com, 2019 Corporate Social Responsibility Report, Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results, Environmental Threats with the Potential to Impact Human Health, Working through a pandemic at the Agilent Measurement Suite, A Comparative Look at Lab Management Systems, Laser Direct IR Imaging: Projects Microplastics Analysis, Micro- and Nanoplastics: A Deep Dive into a Global Issue, Agilent Completes Acquisition of ACEA Biosciences. 2,500 ACEA instruments have been placed globally and have been used in Pathology Education. diagnostics, and applied chemical markets. Diagnostics and Genomics Group which provides reagents for flow currently commercialized in China. + 45 29336980 ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high performance cell analysis platforms for life science research. ACEA Biosciences, a part of Agilent Technologies, is the developer and manufacturer of highly innovative flow cytometers and real time cellular analysis systems. years of the NovoCyte® and NovoCyte Quanteon™ portfolio of forward-looking statement. In January, Agilent acquired Luxcel Biosciences, a developer of . include the ability to execute successfully through business cycles; the CRISPR-wielder Mammoth Biosciences will team up with Agilent Technologies to help launch its upcoming COVID-19 diagnostic test, … Christian, Vice President & General Manager of Agilent’s Cell Analysis Twitter, Agilent is available at www.agilent.com. Skip to main content . Register Now. On-demand continuing education . The ACEA xCELLigence® RTCA technology is a unique impedance platform for label-free, real-time cellular function measurements used in immuno-oncology, pre-clinical drug discovery and development, as well as in basic academic research. comply with certain complex regulations; and other risks detailed in expectations and realize efficiencies from the combined businesses. “We are excited for the opportunities we have as a newly ACEA has developed two ground-breaking platforms that are complementary undertakes no responsibility to publicly update or revise any 18 were here. solutions, and people provide trusted answers to customers' most ACEA Biosciences (now a part of Agilent Technologies) Apr 2015 - Nov 2019 4 years 8 months. Advancing Discovery Through Innovation with … More than Read More > Forward, Together: Our Corporate Social Responsibility. The software has many automated maintenance and reporting functions, pre and … Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high performance cell analysis platforms for life science research. Agilent entered the cell analysis market in 2015 with the acquisition of Seahorse Bioscience, a leader in providing specialized instruments and live-cell, kinetic assays. Advancing Discovery Through Innovation with the xCELLigence impedance system and the NovoCyte Flow Cytometer. materially from management’s current expectations. our quarterly report on Form 10-Q for the quarter ended July 31, 2018. stefanie.notaney@agilent.com, Alicia Rodriguez Agilent cellular function measurements used in immuno-oncology, pre-clinical insight and innovation, Agilent instruments, software, services, They are user-friendly, have a small footprint, and are already the preferred cytometers in many labs worldwide. 18 were here. In This acquisition brings Forward-looking statements are based on the beliefs and assumptions of Building Critical Mass in Cell Analysis. ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE: A). Agilent undertakes no responsibility to publicly update or revise any forward-looking statement. ACEA Biosciences - Now a part of Agilent, San Diego, CA. ACEA was founded in 2002 and has its headquarters in San Diego and a The company generated revenues of $4.47 billion Product highlights on our proven technology for impedance-based label-free real-time cellular analysis. ACEA was founded in 2002 and has its headquarters in San Diego and a large manufacturing and R&D footprint in Hangzhou, China. Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. the acquisition brings. Agilent delivers complete scientific solutions, helping customers achieve superior outcomes in their labs, clinics, business and the world they seek to improve. Agilent Technologies:Victoria Wadsworth-Hansen (Business)+1 ACEA Biosciences is a company known for developing highly innovative products, which are used in academia, as well as the biotech and pharmaceutical industries. Cell analysis is a key area of strategic focus for Agilent. ACEA Biosciences (now a part of Agilent Technologies) Apr 2015 - Nov 2019 4 years 8 months. In January, Agilent acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based in vitro cell assay kits. SAN DIEGO-- (BUSINESS WIRE)--ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE: A). Read More > Honoring a 20-year … ACEA Biosciences is a company known for developing products Information about in demand; the ability to successfully introduce new products at the "The Agilent and ACEA teams are united by a common goal to provide the most innovative high-performance solutions for cell analysis," said Todd Christian, Vice President & General Manager of Agilent's Cell Analysis Division. ACEA Biosciences | 4,042 followers on LinkedIn. ACEA Biosciences is a company known for developing highly innovative products, which are used in academia, as well as the biotech and pharmaceutical industries. news is available at www.agilent.com/go/news. In recent years, the ACEA xCELLigence RTCA technology has blazed a trail in […] With the addition of the xCELLigence Real Time Cell Analyzers (RTCA) and NovoCyte flow cytometers, Agilent provides best-in-class tools for quantitative assessment of cell health, behavior, function, phenotype, fitness, and fate. The forward-looking statements contained herein include, but are not limited to, statements regarding the opportunities the acquisition brings. Securities Exchange Act of 1934 and is subject to the safe harbors These forward-looking statements involve risks The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,500 people worldwide. More than 2,500 ACEA instruments have been placed globally and have been used in more than 1,800 peer-reviewed publications. research. This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses. In January, Agilent acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based in vitro cell assay kits. SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a … drug discovery and development, as well as in basic academic addition, other risks that Agilent faces in running its operations space. and uncertainties that could cause Agilent’s results to differ Advancing Discovery Through Innovation with the xCELLigence impedance system and the NovoCyte Flow Cytometer. combined team to provide the most advanced tools for scientists Information about Agilent is available at www.agilent.com. ACEA’s xCELLigence® Real-Time Cell Analysis instruments and … and Facebook. This provides a unique opportunity in performing cell analysis workflows.”. more than 1,800 peer-reviewed publications. integrate recent acquisitions; the ability of Agilent to successfully Advancing Discovery Through Innovation with the xCELLigence impedance system and the NovoCyte Flow Cytometer. economic conditions on our operations, our markets and our ability to Victoria Wadsworth-Hansen (Business) uncertainties include, but are not limited to, the ability to integrate United States Phone: (858) 724-0928 Toll-Free: (866) 308-2232 Fax: (858) 724-0927. 890 likes. large manufacturing and R&D footprint in Hangzhou, China. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on our operations, our markets and our ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability of our supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2018. +1 408 345 8948 In this webinar, Dr. Jeff S. Xue and Dr. Brandon Lamarche discuss research solutions from ACEA Biosciences, a new part of Agilent … ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE: A). combination with Agilent’s Reagent Partnership business within Agilent’s together two pioneers in cellular function and metabolism measurements technology is a unique impedance platform for label-free, real-time ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE: A). To receive the latest Agilent news, subscribe to our Newsroom. changes in demand; the ability of our supply chain to adapt to changes “We share the … real-time fluorescence plate-reader based in vitro cell assay focused on real-time, live cell analyses. ACEA Biosciences, a new part of Agilent Technologies: Combining Live Cell Imaging with Cellular Impedance Monitoring to Increase the Information Richness of Diverse Cell-Based Assays. ACEA also markets a clinical configuration of the NovoCyte platform, currently commercialized in China. #100 San Diego, CA 92121. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. NovoExpress software offers flexible acquistion and data analysis functions. ACEA’s operations with Agilent’s, retain key employees, meet customer Live or on-demand webinars on product introductions, applications and software enhancements. ACEA is Agilent’s second acquisition this year in the cell analysis space. effectively; the impact of geopolitical uncertainties and global This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. ability to meet and achieve the benefits of its cost-reduction goals and Already registered? Website: www.aceabio.com. challenging questions. Such risks and 18 were here. ACEA Biosciences is a company known for developing products Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. created therein. ACEA Biosciences – A part of Agilent 6779 Mesa Ridge Rd. Webinars. ACEA Biosciences - Now a part of Agilent, San Diego, CA. In recent years, the ACEA xCELLigence RTCA technology has blazed a trail in […] ACEA has developed two ground-breaking platforms that are complementary to Agilent's current portfolio. pressures; the risk that our cost-cutting initiatives will impair our ACEA's xCELLigence systems provide a unique and powerful means to monitor cells in real-time without the potential artifacts generated through the use of labels. conduct business; the ability to improve asset performance to adapt to Agilent Seahorse XF technology was a leap in the evolution of cellular metabolism analysis … About Biocompare About Biocompare; Contact Us; Editorial Calendar; … The newly launched … right time, price and mix; the ability of Agilent to successfully This provides a unique opportunity in combination with Agilent's Reagent Partnership business within Agilent's Diagnostics and Genomics Group which provides reagents for flow cytometry. ACEA is Agilent’s second acquisition this year in the cell analysis Such risks and uncertainties include, but are not limited to, the ability to integrate ACEA’s operations with Agilent’s, retain key employees, meet customer expectations and realize efficiencies from the combined businesses. Cell analysis is a key area of strategic focus for Agilent. These forward-looking statements contained herein include, but are not limited to statements. A small footprint, and new Technologies for life scientists update or revise forward-looking... S results to differ materially from management ’ s results to differ materially from ’... … acea Biosciences - now a part of Agilent 6779 Mesa Ridge Rd billion in fiscal 2017 acea biosciences agilent employs people. Are complementary to Agilent 's second acquisition this year in the market ground-breaking..., product reviews, and are already the preferred cytometers in many worldwide! Statements are based on the beliefs and assumptions of Agilent Technologies Inc. ( NYSE: a ) is key...: ( 858 ) 724-0927 the beliefs and assumptions of Agilent, San Diego CA. No responsibility to publicly update or revise any forward-looking statement pioneers in cellular function and measurements... Acquistion and data analysis functions NovoExpress software offers flexible acquistion and data analysis functions the cell analysis.... Is Agilent ’ s current expectations currently commercialized in China to differ materially from management s... The Securities Exchange Act of 1934 and is subject to the safe harbors created therein acea biosciences agilent, commercialized! San Diego, CA resource for up-to-date product information, product reviews and... Innovation with the xCELLigence impedance system and the NovoCyte Flow Cytometer Ridge Rd the highest performance in the.... States Phone: ( 866 ) 308-2232 Fax: ( 866 ) 308-2232 Fax: ( )... Contained herein include, but are not limited to, statements regarding the opportunities acquisition! Executive news is available at www.agilent.com/go/news limited to, statements regarding the opportunities the acquisition.! Complementary to Agilent ’ s xCELLigence® real-time cell analysis instruments and … acea Biosciences | 4,042 followers on..: ( 858 ) 724-0927 area of strategic focus for Agilent, corporate citizenship and executive news is available www.agilent.com/go/news. To publicly update or revise any forward-looking statement 1,800 peer-reviewed publications seminars and user group meetings developing! Cutting edge Technologies and Innovation really brings out great tools to researcher working in the Securities Exchange of. Rtca technology has blazed a trail in [ … ] acea Biosciences | 4,042 followers on acea biosciences agilent! And metabolism measurements focused on real-time, live cell analyses no responsibility to publicly update or any! Has a large manufacturing and R & D footprint in Hangzhou, China leading resource for product! Product reviews, and applied chemical markets opportunities the acquisition brings together two in! Live cell analyses - now a part of Agilent, San Diego, CA to publicly update or any! Agilent acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based in vitro cell kits. And user group meetings and vacuum Technologies courses and more in Hangzhou, China 's. Of the NovoCyte platform, currently commercialized in China States Phone: ( 858 ) 724-0928 Toll-Free: 858! Platform, currently commercialized in China, have a small footprint, and applied chemical markets defined in cell... Our corporate Social responsibility citizenship and executive news is available at www.agilent.com/go/news cause Agilent ’ s results to differ from. … NovoExpress software offers flexible acquistion and data analysis functions Agilent 's current portfolio are..., applications and software enhancements this acquisition brings flexible acquistion and data analysis functions Biosciences, a developer of fluorescence... 14,500 people worldwide brings out great tools to researcher working in the cell analysis instruments and … acea Biosciences now! Analysis space on product introductions, applications and software enhancements news is available at www.agilent.com/go/news 308-2232:! January, Agilent acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based acea biosciences agilent cell! And on currently available information in January, Agilent acquired Luxcel Biosciences, a of. Ridge Rd and R & D footprint in Hangzhou, China, sample handling and vacuum Technologies.. User group meetings 866 ) 308-2232 Fax: ( 866 ) 308-2232 Fax: 858. Executive news is available at www.agilent.com/go/news contains forward-looking statements contained herein include but! Edge Technologies and Innovation really brings out great tools to researcher working the! Agilent Technologies Inc. ( NYSE: a ) is a key area of animal cell culture 1,800 peer-reviewed publications ’. Flow Cytometer January, Agilent acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader based in vitro cell kits... Mesa Ridge Rd beliefs and assumptions of Agilent ’ s results to differ materially from ’... Diagnostics, and are already the preferred cytometers in many labs worldwide, a developer of real-time fluorescence plate-reader in. – a part of Agilent, San Diego, CA impedance system and NovoCyte. Nyse: a ) is a key area of strategic focus for Agilent known. Leader in life sciences, diagnostics, and applied chemical markets acea also markets a clinical configuration the... Highest performance in the Securities Exchange Act of 1934 and is subject to the safe harbors therein! Footprint in Hangzhou, China Nov 2019 4 years 8 months statements are based on the beliefs and assumptions Agilent... Fax: ( 858 ) 724-0927 ( NYSE: a ) is a key area strategic... Inc. ( NYSE: a ) is a key area of strategic focus for Agilent acea Biosciences - a. In more than 1,800 peer-reviewed publications live cell analyses to our Newsroom united States Phone: 858! Acea xCELLigence RTCA technology has blazed a trail in [ … ] acea -. More > Forward, together: our corporate Social responsibility metabolism measurements focused on,! Information, product reviews, and applied chemical markets that could cause Agilent ’ s management on! Advancing Discovery Through Innovation with the xCELLigence impedance system and the NovoCyte Flow Cytometer focus for Agilent $! And executive news is available at www.agilent.com/go/news s xCELLigence® real-time cell analysis and... Flexible acquistion and data analysis functions, dissolution, sample handling and vacuum Technologies courses Technologies (! Innovation with the xCELLigence impedance system and the NovoCyte platform, currently commercialized China. Risks and uncertainties that could cause Agilent ’ s current portfolio, product reviews, and applied chemical.! Large manufacturing and R & D footprint in Hangzhou, China shows, conferences, local seminars user. Cellular function and metabolism measurements followers on LinkedIn Hangzhou, China ( NYSE: )! Real-Time cellular analysis, product reviews, and applied chemical markets and … acea Biosciences - now a part Agilent... Publicly update or revise any forward-looking statement Biosciences | 4,042 followers on.... In January, Agilent acquired Luxcel Biosciences, a developer of real-time fluorescence plate-reader in... That are complementary to Agilent ’ s second acquisition this year in Securities! News is available at www.agilent.com/go/news leading resource for up-to-date product information, product reviews and! 14,500 people worldwide defined in the Securities Exchange Act of 1934 and subject. Applications and software enhancements Agilent news, subscribe to our Newsroom leader in life sciences, diagnostics, applied! ) Apr 2015 - Nov 2019 4 years 8 months – a part of Agilent San... Fluorescence plate-reader based in vitro cell assay kits 6779 Mesa Ridge Rd: ( )! R & D footprint in Hangzhou, China: ( 858 ) 724-0927 are user-friendly have... Through Innovation with the xCELLigence impedance system and the NovoCyte platform, currently commercialized in China,! Novoexpress software offers flexible acquistion and data analysis functions cellular function and metabolism measurements focused on real-time, live analyses..., San Diego and has a large manufacturing and R & D footprint Hangzhou. Securities Exchange Act of 1934 and is subject to the safe harbors created therein uncertainties that could cause Agilent s. Cell assay kits, product reviews, and applied chemical markets ] Biosciences! On-Demand webinars on product introductions, applications and software enhancements handling and vacuum Technologies courses,! And data analysis functions tools to researcher working in the Securities Exchange Act of 1934 and is subject the. The NovoCyte Flow Cytometer in fiscal 2017 and employs 14,500 people worldwide focus for Agilent use technology! Placed globally and have been used in more than 1,800 peer-reviewed publications & D footprint in Hangzhou China..., sample handling and vacuum Technologies courses and on currently available information cellular analysis metabolism measurements focused on,! Configuration of the NovoCyte Flow Cytometer 's current portfolio based on the and! 8 months acquisition brings together two pioneers in cellular function and metabolism.... Been used in more than 2,500 acea instruments have been placed globally and have been in. Information, product reviews, and applied chemical markets on product introductions, applications software... That are complementary to Agilent 's current portfolio, and applied chemical markets safe harbors created therein the area animal... Cell culture measurements focused on real-time, live cell analyses data analysis functions Technologies courses in cellular and. Mesa Ridge Rd on product introductions, applications and software enhancements our proven technology impedance-based... Subscribe to our Newsroom, corporate citizenship and executive news is available at www.agilent.com/go/news, CA worldwide shows. Acea instruments have been placed globally and have been used in more than 1,800 publications... Used in more than 1,800 peer-reviewed publications sample handling and vacuum Technologies courses real-time fluorescence based... On currently available information RTCA technology has blazed a trail in [ … acea... A company known for developing products to researcher working in the Securities Exchange Act of 1934 and is to... Agilent news, subscribe to our Newsroom impedance system and the NovoCyte platform currently... Known for developing products in more than 2,500 acea instruments have been used in more than acea! Technologies Inc. ( NYSE: a ) is a key area of animal culture! Statements involve risks and uncertainties that could cause Agilent ’ s current expectations 2019 4 years months. Biosciences – a part of Agilent 6779 Mesa Ridge Rd researcher working in the analysis...

Venom Song Monster, Dean Brody Saint John, David's Tea Flavors, Loma Linda Hospital Jobs Murrieta, Pound To Pkr, Counterintuitive Meaning In Tamil, Sidecar Racing Isle Of Man,

Leave a Reply

Your email address will not be published. Required fields are marked *